On July 18th, a Memorandum of Understanding (MOU) was signed between BGI Genomics, Faculty Of Medicine Siriraj Hospital at Mahidol University, Bangkok Genomics Innovation Public Company (the BGI Genomics Thailand Joint Venture Company), and Hemogen Hong Kong Alpha Technology, Ltd.

This agreement focuses on enhancing Thalassemia prevention and treatment initiatives and facilitating collaborative efforts in cellular and gene therapy development.

Advancing prevention and treatment in Thailand comes via ChinaTechNews.com.